0001654954-22-000127.txt : 20220104 0001654954-22-000127.hdr.sgml : 20220104 20220104142717 ACCESSION NUMBER: 0001654954-22-000127 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220104 DATE AS OF CHANGE: 20220104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tsuchimoto Kim R CENTRAL INDEX KEY: 0001333516 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39070 FILM NUMBER: 22505279 MAIL ADDRESS: STREET 1: C/O MONOPAR THERAPEUTICS INC. STREET 2: 1000 SKOKIE BLVD., SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monopar Therapeutics CENTRAL INDEX KEY: 0001645469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320463781 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 BUSINESS PHONE: 8473880349 MAIL ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2021-12-31 false 0001645469 Monopar Therapeutics MNPR 0001333516 Tsuchimoto Kim R 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 false true false false Chief Financial Officer Common Stock 2021-12-31 4 M false 1221 A 4690 D Common Stock 2021-12-31 4 F false 501 3.21 D 4189 D Restricted Stock Units 2021-12-31 4 M false 1221 0 D Common Stock 1221 14652 D Represents shares acquired on vesting and settlement of restricted stock units. On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. /s/ Kim R. Tsuchimoto 2022-01-04